List of Tables
    Table 1. Dermatomycoses Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Dermatomycoses Drug Market Trends
    Table 3. Dermatomycoses Drug Market Drivers
    Table 4. Dermatomycoses Drug Market Challenges
    Table 5. Dermatomycoses Drug Market Restraints
    Table 6. Global Dermatomycoses Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Dermatomycoses Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Dermatomycoses Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Dermatomycoses Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Dermatomycoses Drug Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Dermatomycoses Drug Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Dermatomycoses Drug Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Dermatomycoses Drug Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Dermatomycoses Drug Sales Share by Manufacturer, 2017-2022
    Table 15. Global Dermatomycoses Drug Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Dermatomycoses Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Dermatomycoses Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatomycoses Drug as of 2021)
    Table 18. Top Players of Dermatomycoses Drug in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Dermatomycoses Drug Product Type
    Table 20. Date of International Manufacturers Enter into Dermatomycoses Drug Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Dermatomycoses Drug Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Dermatomycoses Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Dermatomycoses Drug Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Dermatomycoses Drug Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Dermatomycoses Drug Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Dermatomycoses Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Dermatomycoses Drug Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Dermatomycoses Drug Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Dermatomycoses Drug Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Dermatomycoses Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Dermatomycoses Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Dermatomycoses Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Dermatomycoses Drug Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Dermatomycoses Drug Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Dermatomycoses Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Dermatomycoses Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Dermatomycoses Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Dermatomycoses Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Dermatomycoses Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Dermatomycoses Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Anacor Pharmaceuticals Inc Corporation Information
    Table 43. Anacor Pharmaceuticals Inc Description and Business Overview
    Table 44. Anacor Pharmaceuticals Inc Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Anacor Pharmaceuticals Inc Dermatomycoses Drug Product
    Table 46. Anacor Pharmaceuticals Inc Recent Development
    Table 47. Biolab Farmaceutica Ltda Corporation Information
    Table 48. Biolab Farmaceutica Ltda Description and Business Overview
    Table 49. Biolab Farmaceutica Ltda Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Biolab Farmaceutica Ltda Product
    Table 51. Biolab Farmaceutica Ltda Recent Development
    Table 52. Blueberry Therapeutics Ltd Corporation Information
    Table 53. Blueberry Therapeutics Ltd Description and Business Overview
    Table 54. Blueberry Therapeutics Ltd Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Blueberry Therapeutics Ltd Product
    Table 56. Blueberry Therapeutics Ltd Recent Development
    Table 57. Daewoong Pharmaceutical Co Ltd Corporation Information
    Table 58. Daewoong Pharmaceutical Co Ltd Description and Business Overview
    Table 59. Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Daewoong Pharmaceutical Co Ltd Product
    Table 61. Daewoong Pharmaceutical Co Ltd Recent Development
    Table 62. Dermala Inc Corporation Information
    Table 63. Dermala Inc Description and Business Overview
    Table 64. Dermala Inc Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Dermala Inc Product
    Table 66. Dermala Inc Recent Development
    Table 67. Helix BioMedix Inc Corporation Information
    Table 68. Helix BioMedix Inc Description and Business Overview
    Table 69. Helix BioMedix Inc Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Helix BioMedix Inc Product
    Table 71. Helix BioMedix Inc Recent Development
    Table 72. Novan Inc Corporation Information
    Table 73. Novan Inc Description and Business Overview
    Table 74. Novan Inc Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Novan Inc Product
    Table 76. Novan Inc Recent Development
    Table 77. Sol-Gel Technologies Ltd Corporation Information
    Table 78. Sol-Gel Technologies Ltd Description and Business Overview
    Table 79. Sol-Gel Technologies Ltd Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Sol-Gel Technologies Ltd Product
    Table 81. Sol-Gel Technologies Ltd Recent Development
    Table 82. TGV-Laboratories Corporation Information
    Table 83. TGV-Laboratories Description and Business Overview
    Table 84. TGV-Laboratories Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. TGV-Laboratories Product
    Table 86. TGV-Laboratories Recent Development
    Table 87. Viamet Pharmaceuticals Inc Corporation Information
    Table 88. Viamet Pharmaceuticals Inc Description and Business Overview
    Table 89. Viamet Pharmaceuticals Inc Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Viamet Pharmaceuticals Inc Product
    Table 91. Viamet Pharmaceuticals Inc Recent Development
    Table 92. Vyome Biosciences Pvt Ltd Corporation Information
    Table 93. Vyome Biosciences Pvt Ltd Description and Business Overview
    Table 94. Vyome Biosciences Pvt Ltd Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Vyome Biosciences Pvt Ltd Product
    Table 96. Vyome Biosciences Pvt Ltd Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Dermatomycoses Drug Customers List
    Table 100. Dermatomycoses Drug Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dermatomycoses Drug Product Picture
    Figure 2. Global Dermatomycoses Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Dermatomycoses Drug Market Size 2017-2028 (US$ Million)
    Figure 4. Global Dermatomycoses Drug Sales 2017-2028 (K Units)
    Figure 5. United States Dermatomycoses Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Dermatomycoses Drug Market Size 2017-2028 (US$ Million)
    Figure 7. United States Dermatomycoses Drug Sales 2017-2028 (K Units)
    Figure 8. United States Dermatomycoses Drug Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Dermatomycoses Drug Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Dermatomycoses Drug Report Years Considered
    Figure 11. Product Picture of BB-2603
    Figure 12. Product Picture of Clotrimazole
    Figure 13. Product Picture of Dapaconazole
    Figure 14. Product Picture of Others
    Figure 15. Global Dermatomycoses Drug Market Share by Type in 2022 & 2028
    Figure 16. Global Dermatomycoses Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Dermatomycoses Drug Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Dermatomycoses Drug Sales by Type (2017-2028) & (K Units)
    Figure 19. Global Dermatomycoses Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Dermatomycoses Drug Price by Type (2017-2028) & (USD/Unit)
    Figure 21. United States Dermatomycoses Drug Market Share by Type in 2022 & 2028
    Figure 22. United States Dermatomycoses Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Dermatomycoses Drug Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Dermatomycoses Drug Sales by Type (2017-2028) & (K Units)
    Figure 25. United States Dermatomycoses Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Dermatomycoses Drug Price by Type (2017-2028) & (USD/Unit)
    Figure 27. Product Picture of Hospital
    Figure 28. Product Picture of Clinic
    Figure 29. Product Picture of Others
    Figure 30. Global Dermatomycoses Drug Market Share by Application in 2022 & 2028
    Figure 31. Global Dermatomycoses Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Dermatomycoses Drug Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Dermatomycoses Drug Sales by Application (2017-2028) & (K Units)
    Figure 34. Global Dermatomycoses Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Dermatomycoses Drug Price by Application (2017-2028) & (USD/Unit)
    Figure 36. United States Dermatomycoses Drug Market Share by Application in 2022 & 2028
    Figure 37. United States Dermatomycoses Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Dermatomycoses Drug Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Dermatomycoses Drug Sales by Application (2017-2028) & (K Units)
    Figure 40. United States Dermatomycoses Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Dermatomycoses Drug Price by Application (2017-2028) & (USD/Unit)
    Figure 42. North America Dermatomycoses Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 43. North America Dermatomycoses Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Dermatomycoses Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 47. Europe Dermatomycoses Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Dermatomycoses Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 54. Asia-Pacific Dermatomycoses Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Dermatomycoses Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 66. Latin America Dermatomycoses Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Dermatomycoses Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 71. Middle East & Africa Dermatomycoses Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. U.A.E Dermatomycoses Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Dermatomycoses Drug Value Chain
    Figure 76. Dermatomycoses Drug Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed